Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06947993 · RECRUITING
Trial details
- NCT number
- NCT06947993
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-16
- Primary completion
- 2028-11-27
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.